GDF10 inhibits cell proliferation and epithelial–mesenchymal transition in nasopharyngeal carcinoma by the transforming growth factor-β/Smad and NF-κB pathways

Abstract Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead to carcinoma progression. Previous studies have shown that GDF10 acts as a tumor suppressor gene in some cancers. However, the mole...

Full description

Saved in:
Bibliographic Details
Published inCarcinogenesis (New York) Vol. 43; no. 2; pp. 94 - 103
Main Authors He, Feng, Feng, Guofei, Ma, Ning, Midorikawa, Kaoru, Oikawa, Shinji, Kobayashi, Hatasu, Zhang, Zhe, Huang, Guangwu, Takeuchi, Kazuhiko, Murata, Mariko
Format Journal Article
LanguageEnglish
Published UK Oxford University Press 24.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead to carcinoma progression. Previous studies have shown that GDF10 acts as a tumor suppressor gene in some cancers. However, the molecular mechanisms of the association between GDF10 and cell functions in nasopharyngeal carcinoma (NPC) remain unclear. In this study, the expression and methylation levels of GDF10 were studied in human subjects and cell lines. Furthermore, overexpression of GDF10 was used to explore its biological function and potential mechanism in NPC cell lines. GDF10 was downregulated in NPC owing to its aberrant promoter methylation. After treatment with 5-aza-2′-deoxycytidine, the expression of GDF10 in NPC cells was reversed. We also confirmed that the overexpression of GDF10 significantly inhibited cell proliferation and tumor growth both in vitro and in vivo, respectively. Additionally, GDF10 overexpression in NPC cells attenuated migration and invasion and inhibited epithelial-to-mesenchymal transition with a decrease in nuclear Smad2 and NF-κB protein accumulation. GDF10 was silenced owing to its promoter hypermethylation, and it might originally act as a functional tumor suppressor via TGF-β/Smad and NF-κB signaling pathways in NPC. Graphical Abstract Graphical Abstract
AbstractList Abstract Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead to carcinoma progression. Previous studies have shown that GDF10 acts as a tumor suppressor gene in some cancers. However, the molecular mechanisms of the association between GDF10 and cell functions in nasopharyngeal carcinoma (NPC) remain unclear. In this study, the expression and methylation levels of GDF10 were studied in human subjects and cell lines. Furthermore, overexpression of GDF10 was used to explore its biological function and potential mechanism in NPC cell lines. GDF10 was downregulated in NPC owing to its aberrant promoter methylation. After treatment with 5-aza-2′-deoxycytidine, the expression of GDF10 in NPC cells was reversed. We also confirmed that the overexpression of GDF10 significantly inhibited cell proliferation and tumor growth both in vitro and in vivo, respectively. Additionally, GDF10 overexpression in NPC cells attenuated migration and invasion and inhibited epithelial-to-mesenchymal transition with a decrease in nuclear Smad2 and NF-κB protein accumulation. GDF10 was silenced owing to its promoter hypermethylation, and it might originally act as a functional tumor suppressor via TGF-β/Smad and NF-κB signaling pathways in NPC. Graphical Abstract Graphical Abstract
Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead to carcinoma progression. Previous studies have shown that GDF10 acts as a tumor suppressor gene in some cancers. However, the molecular mechanisms of the association between GDF10 and cell functions in nasopharyngeal carcinoma (NPC) remain unclear. In this study, the expression and methylation levels of GDF10 were studied in human subjects and cell lines. Furthermore, overexpression of GDF10 was used to explore its biological function and potential mechanism in NPC cell lines. GDF10 was downregulated in NPC owing to its aberrant promoter methylation. After treatment with 5-aza-2′-deoxycytidine, the expression of GDF10 in NPC cells was reversed. We also confirmed that the overexpression of GDF10 significantly inhibited cell proliferation and tumor growth both in vitro and in vivo, respectively. Additionally, GDF10 overexpression in NPC cells attenuated migration and invasion and inhibited epithelial-to-mesenchymal transition with a decrease in nuclear Smad2 and NF-κB protein accumulation. GDF10 was silenced owing to its promoter hypermethylation, and it might originally act as a functional tumor suppressor via TGF-β/Smad and NF-κB signaling pathways in NPC.
Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead to carcinoma progression. Previous studies have shown that GDF10 acts as a tumor suppressor gene in some cancers. However, the molecular mechanisms of the association between GDF10 and cell functions in nasopharyngeal carcinoma (NPC) remain unclear. In this study, the expression and methylation levels of GDF10 were studied in human subjects and cell lines. Furthermore, overexpression of GDF10 was used to explore its biological function and potential mechanism in NPC cell lines. GDF10 was downregulated in NPC owing to its aberrant promoter methylation. After treatment with 5-aza-2'-deoxycytidine, the expression of GDF10 in NPC cells was reversed. We also confirmed that the overexpression of GDF10 significantly inhibited cell proliferation and tumor growth both in vitro and in vivo, respectively. Additionally, GDF10 overexpression in NPC cells attenuated migration and invasion and inhibited epithelial-to-mesenchymal transition with a decrease in nuclear Smad2 and NF-κB protein accumulation. GDF10 was silenced owing to its promoter hypermethylation, and it might originally act as a functional tumor suppressor via TGF-β/Smad and NF-κB signaling pathways in NPC.Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead to carcinoma progression. Previous studies have shown that GDF10 acts as a tumor suppressor gene in some cancers. However, the molecular mechanisms of the association between GDF10 and cell functions in nasopharyngeal carcinoma (NPC) remain unclear. In this study, the expression and methylation levels of GDF10 were studied in human subjects and cell lines. Furthermore, overexpression of GDF10 was used to explore its biological function and potential mechanism in NPC cell lines. GDF10 was downregulated in NPC owing to its aberrant promoter methylation. After treatment with 5-aza-2'-deoxycytidine, the expression of GDF10 in NPC cells was reversed. We also confirmed that the overexpression of GDF10 significantly inhibited cell proliferation and tumor growth both in vitro and in vivo, respectively. Additionally, GDF10 overexpression in NPC cells attenuated migration and invasion and inhibited epithelial-to-mesenchymal transition with a decrease in nuclear Smad2 and NF-κB protein accumulation. GDF10 was silenced owing to its promoter hypermethylation, and it might originally act as a functional tumor suppressor via TGF-β/Smad and NF-κB signaling pathways in NPC.
Author Huang, Guangwu
Midorikawa, Kaoru
Kobayashi, Hatasu
Oikawa, Shinji
Takeuchi, Kazuhiko
Ma, Ning
Feng, Guofei
He, Feng
Zhang, Zhe
Murata, Mariko
Author_xml – sequence: 1
  givenname: Feng
  surname: He
  fullname: He, Feng
  organization: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan
– sequence: 2
  givenname: Guofei
  surname: Feng
  fullname: Feng, Guofei
  organization: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan
– sequence: 3
  givenname: Ning
  surname: Ma
  fullname: Ma, Ning
  organization: Graduate School of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Japan
– sequence: 4
  givenname: Kaoru
  surname: Midorikawa
  fullname: Midorikawa, Kaoru
  organization: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan
– sequence: 5
  givenname: Shinji
  surname: Oikawa
  fullname: Oikawa, Shinji
  organization: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan
– sequence: 6
  givenname: Hatasu
  surname: Kobayashi
  fullname: Kobayashi, Hatasu
  organization: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan
– sequence: 7
  givenname: Zhe
  surname: Zhang
  fullname: Zhang, Zhe
  organization: Department of Otolaryngology-Head and Neck Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China
– sequence: 8
  givenname: Guangwu
  orcidid: 0000-0002-7376-5691
  surname: Huang
  fullname: Huang, Guangwu
  organization: Key Laboratory of High-Incidence-Tumor Prevention and Treatment, Guangxi Medical University, Nanning, China
– sequence: 9
  givenname: Kazuhiko
  surname: Takeuchi
  fullname: Takeuchi, Kazuhiko
  email: kazuhiko@med.mie-u.ac.jp
  organization: Department of Otolaryngology-Head and Neck Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan
– sequence: 10
  givenname: Mariko
  orcidid: 0000-0003-3668-7214
  surname: Murata
  fullname: Murata, Mariko
  email: mmurata@med.mie-u.ac.jp
  organization: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34922336$$D View this record in MEDLINE/PubMed
BookMark eNqFkU9u1DAUxi1URKeFLUvkJSzS8b94kiUUpq1UwQJYR8-OMzFK7GB7VM2ud-gRuAFLDtFDcBLcycACCSE_yQv_vvf8vu8EHTnvDELPKTmjpOZLDUFbt1QbUJSxR2hBhSQFoxU5QgtCBS845-IYncT4hRAqeVk_Qcdc1IxxLhfo28XbNSXYut4qmyLWZhjwFPxgOxMgWe8wuBabyabeDBaGn7d3o4nG6X43woBTABftnrMOO4h-6iHs3Mbkx_lzfgSsdjjrZ7rzYbRugzfB36Qed6CTD8X99-XHEdr9tPfr4v7HGzxB6m9gF5-ixx0M0Tw73Kfo8_rdp_PL4vrDxdX56-tCc1anQlZdp0WlQArGDa9WsuxqsgIhhdatElJTVcp8KqW6XK2pqCDVivGa81ZQfopezn3z_l-3JqZmtPHBEHDGb2PDJKWy5CtSZvTFAd2q0bTNFOyY125-G5uBsxnQwccYTPcHoaR5SK6ZzWkOyWWB-EugbdoHkE2zw79lr2aZ307_G_ELXbOzqw
CitedBy_id crossref_primary_10_1155_2022_7117083
crossref_primary_10_3892_ol_2023_13977
crossref_primary_10_1002_hed_27569
crossref_primary_10_1186_s40001_024_01932_2
crossref_primary_10_1093_carcin_bgae054
crossref_primary_10_1016_j_omton_2024_200858
crossref_primary_10_1016_j_xgen_2023_100411
Cites_doi 10.1016/j.yexcr.2018.11.021
10.1593/neo.05625
10.1016/j.radonc.2019.04.025
10.1186/s13046-017-0554-9
10.12688/f1000research.18872.1
10.1158/1535-7163.MCT-15-0260
10.1016/j.imlet.2019.01.007
10.1073/pnas.1103441108
10.1002/mc.22297
10.3389/fcell.2020.00417
10.1016/j.canlet.2013.05.018
10.18632/aging.101983
10.1038/sj.onc.1207441
10.1016/S1044579X02000883
10.1002/cam4.451
10.3892/ol.2014.2322
10.5487/TR.2010.26.4.245
10.1158/0008-5472.CAN-17-1051
10.1038/onc.2012.171
10.18632/oncotarget.23826
10.1101/cshperspect.a022137
10.1158/1541-7786.MCR-17-0134
10.1007/s00726-018-2651-2
10.1093/jjco/hyg092
10.4103/0976-500X.119726
10.7150/ijbs.7.1056
10.1158/1055-9965.EPI-06-0353
10.1016/j.radonc.2013.10.020
10.1038/sj.neo.7900162
10.2147/DDDT.S199182
10.1002/ijc.25173
ContentType Journal Article
Copyright The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2021
The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Copyright_xml – notice: The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2021
– notice: The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/carcin/bgab122
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1460-2180
EndPage 103
ExternalDocumentID 34922336
10_1093_carcin_bgab122
10.1093/carcin/bgab122
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Japan Society for the Promotion of Science
  grantid: JP16H05829
GroupedDBID ---
-E4
.2P
.55
.GJ
.I3
.ZR
0R~
18M
1TH
29B
2WC
3O-
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
6.Y
6J9
70D
A8Z
AABZA
AACZT
AAIMJ
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAVLN
AAWDT
ABDFA
ABEFU
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABMNT
ABNGD
ABNHQ
ABNKS
ABPTD
ABQLI
ABQTQ
ABSAR
ABSMQ
ABVGC
ABWST
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACMRT
ACNCT
ACPQN
ACPRK
ACUFI
ACUTJ
ACUTO
ACZBC
ADBBV
ADEYI
ADEZT
ADFTL
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZTZ
ADZXQ
AEGPL
AEGXH
AEHUL
AEJOX
AEKPW
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFQV
AFFZL
AFGWE
AFIYH
AFOFC
AFRAH
AFSHK
AFXEN
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGQXC
AGSYK
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJEEA
AKHUL
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ANFBD
APIBT
APJGH
APWMN
AQDSO
AQKUS
ARIXL
ASAOO
ASPBG
ATDFG
ATGXG
ATTQO
AVWKF
AXUDD
AYOIW
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BSWAC
BTRTY
BVRKM
BZKNY
C1A
C45
CAG
CDBKE
COF
CS3
CXTWN
CZ4
DAKXR
DFGAJ
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EE~
EIHJH
EJD
ELUNK
EMOBN
F5P
F9B
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
FRP
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IH2
IOX
J21
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
M-Z
M49
MBLQV
MBTAY
N9A
NGC
NLBLG
NOMLY
NOYVH
NTWIH
NU-
NVLIB
O0~
O9-
OAWHX
OBOKY
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RHF
RIG
RNI
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
SV3
TCN
TEORI
TJX
TLC
TMA
TR2
W8F
WOQ
X7H
X7M
XOL
YAYTL
YKOAZ
YXANX
ZGI
ZKB
ZKX
ZXP
~91
AAYXX
ABPQP
ABXZS
ADNBA
AGORE
AHGBF
AJBYB
AJNCP
ALXQX
CITATION
JXSIZ
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c329t-68ffc48ba6423e38765f907a464ccdb46c1b565658bbfbbfde81408723933d413
ISSN 0143-3334
1460-2180
IngestDate Thu Jul 10 18:40:27 EDT 2025
Thu Apr 03 06:57:54 EDT 2025
Thu Apr 24 22:56:58 EDT 2025
Tue Jul 01 04:21:35 EDT 2025
Tue Feb 11 07:50:34 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c329t-68ffc48ba6423e38765f907a464ccdb46c1b565658bbfbbfde81408723933d413
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-3668-7214
0000-0002-7376-5691
PMID 34922336
PQID 2611653705
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_2611653705
pubmed_primary_34922336
crossref_primary_10_1093_carcin_bgab122
crossref_citationtrail_10_1093_carcin_bgab122
oup_primary_10_1093_carcin_bgab122
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-03-24
PublicationDateYYYYMMDD 2022-03-24
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-24
  day: 24
PublicationDecade 2020
PublicationPlace UK
PublicationPlace_xml – name: UK
– name: England
PublicationTitle Carcinogenesis (New York)
PublicationTitleAlternate Carcinogenesis
PublicationYear 2022
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Dai (2022032516110725200_CIT0007) 2004; 23
Zhou (2022032516110725200_CIT0010) 2019; 11
Lan (2022032516110725200_CIT0035) 2011; 7
Suwannakul (2022032516110725200_CIT0022) 2020; 8
Liang (2022032516110725200_CIT0025) 2019; 13
Dai (2022032516110725200_CIT0029) 2001; 3
Yamashita (2022032516110725200_CIT0034) 2019; 207
Gilmore (2022032516110725200_CIT0030) 2019; 8
Son (2022032516110725200_CIT0032) 2010; 26
Sun (2022032516110725200_CIT0004) 2014; 110
Dai (2022032516110725200_CIT0013) 2015; 4
Zhang (2022032516110725200_CIT0015) 2017; 15
Yu-Lee (2022032516110725200_CIT0006) 2018; 78
Huang (2022032516110725200_CIT0031) 2019; 374
Zhao (2022032516110725200_CIT0020) 2017; 36
Gos (2022032516110725200_CIT0024) 2009; 55
Luo (2022032516110725200_CIT0012) 2017; 9
Lo (2022032516110725200_CIT0028) 2002; 12
Jiang (2022032516110725200_CIT0014) 2015; 14
Li (2022032516110725200_CIT0011) 2017; 38
Chang (2022032516110725200_CIT0001) 2006; 15
Kimura (2022032516110725200_CIT0008) 2008; 20
He (2022032516110725200_CIT0019) 2018; 50
Xue (2022032516110725200_CIT0026) 2018; 15
Yoshizaki (2022032516110725200_CIT0023) 2013; 337
Tsang (2022032516110725200_CIT0017) 2010; 127
Charan (2022032516110725200_CIT0021) 2013; 4
Park (2022032516110725200_CIT0009) 2014; 8
Lo (2022032516110725200_CIT0016) 2006; 8
Upadhyay (2022032516110725200_CIT0027) 2011; 108
Yao (2022032516110725200_CIT0002) 2019; 137
Freudlsperger (2022032516110725200_CIT0033) 2013; 32
Hou (2022032516110725200_CIT0018) 2018; 9
Liu (2022032516110725200_CIT0003) 2003; 33
Cheng (2022032516110725200_CIT0005) 2016; 55
References_xml – volume: 374
  start-page: 172
  year: 2019
  ident: 2022032516110725200_CIT0031
  article-title: Placenta specific 8 gene induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via the TGF-β/Smad pathway
  publication-title: Exp. Cell Res.,
  doi: 10.1016/j.yexcr.2018.11.021
– volume: 8
  start-page: 173
  year: 2006
  ident: 2022032516110725200_CIT0016
  article-title: Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells
  publication-title: Neoplasia,
  doi: 10.1593/neo.05625
– volume: 137
  start-page: 137
  year: 2019
  ident: 2022032516110725200_CIT0002
  article-title: Clinical features and survival outcomes between ascending and descending types of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysis
  publication-title: Radiother. Oncol.,
  doi: 10.1016/j.radonc.2019.04.025
– volume: 36
  start-page: 88
  year: 2017
  ident: 2022032516110725200_CIT0020
  article-title: RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma
  publication-title: J. Exp. Clin. Cancer Res.,
  doi: 10.1186/s13046-017-0554-9
– volume: 8
  start-page: 1793
  year: 2019
  ident: 2022032516110725200_CIT0030
  article-title: Emerging approaches to target mitochondrial apoptosis in cancer cells
  publication-title: F1000Res
  doi: 10.12688/f1000research.18872.1
– volume: 14
  start-page: 2864
  year: 2015
  ident: 2022032516110725200_CIT0014
  article-title: Genome-wide identification of a methylation gene panel as a prognostic biomarker in nasopharyngeal carcinoma
  publication-title: Mol. Cancer Ther.,
  doi: 10.1158/1535-7163.MCT-15-0260
– volume: 38
  start-page: 206
  year: 2017
  ident: 2022032516110725200_CIT0011
  article-title: Rediscovery of the sun bear (Helarctos malayanus) in Yingjiang County, Yunnan Province, China
  publication-title: Zool. Res.,
– volume: 207
  start-page: 64
  year: 2019
  ident: 2022032516110725200_CIT0034
  article-title: Genetic variants of SMAD2/3/4/7 are associated with susceptibility to ulcerative colitis in a Japanese genetic background
  publication-title: Immunol. Lett.,
  doi: 10.1016/j.imlet.2019.01.007
– volume: 108
  start-page: 7820
  year: 2011
  ident: 2022032516110725200_CIT0027
  article-title: Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling
  publication-title: Proc. Natl. Acad. Sci. USA,
  doi: 10.1073/pnas.1103441108
– volume: 55
  start-page: 499
  year: 2016
  ident: 2022032516110725200_CIT0005
  article-title: Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma
  publication-title: Mol. Carcinog.,
  doi: 10.1002/mc.22297
– volume: 20
  start-page: 1265
  year: 2008
  ident: 2022032516110725200_CIT0008
  article-title: The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas
  publication-title: Oncol. Rep.,
– volume: 8
  start-page: 417
  year: 2020
  ident: 2022032516110725200_CIT0022
  article-title: CD44v9 induces stem cell-like phenotypes in human cholangiocarcinoma
  publication-title: Front. Cell Dev. Biol.,
  doi: 10.3389/fcell.2020.00417
– volume: 337
  start-page: 1
  year: 2013
  ident: 2022032516110725200_CIT0023
  article-title: Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma
  publication-title: Cancer Lett.,
  doi: 10.1016/j.canlet.2013.05.018
– volume: 11
  start-page: 3298
  year: 2019
  ident: 2022032516110725200_CIT0010
  article-title: GDF10 inhibits proliferation and epithelial-mesenchymal transition in triple-negative breast cancer via upregulation of Smad7
  publication-title: Aging (Albany. NY).,
  doi: 10.18632/aging.101983
– volume: 23
  start-page: 3521
  year: 2004
  ident: 2022032516110725200_CIT0007
  article-title: Bone morphogenetic protein 3B silencing in non-small-cell lung cancer
  publication-title: Oncogene,
  doi: 10.1038/sj.onc.1207441
– volume: 12
  start-page: 451
  year: 2002
  ident: 2022032516110725200_CIT0028
  article-title: Genetic and epigenetic changes in nasopharyngeal carcinoma
  publication-title: Semin. Cancer Biol.,
  doi: 10.1016/S1044579X02000883
– volume: 4
  start-page: 1079
  year: 2015
  ident: 2022032516110725200_CIT0013
  article-title: Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma
  publication-title: Cancer Med.,
  doi: 10.1002/cam4.451
– volume: 8
  start-page: 1613
  year: 2014
  ident: 2022032516110725200_CIT0009
  article-title: Microarray-based DNA methylation study of Ewing’s sarcoma of the bone
  publication-title: Oncol. Lett.,
  doi: 10.3892/ol.2014.2322
– volume: 26
  start-page: 245
  year: 2010
  ident: 2022032516110725200_CIT0032
  article-title: Epithelial-mesenchymal transition and cell invasion
  publication-title: Toxicol. Res.,
  doi: 10.5487/TR.2010.26.4.245
– volume: 78
  start-page: 2911
  year: 2018
  ident: 2022032516110725200_CIT0006
  article-title: Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the TGFβRIII-p38MAPK-pS249/T252RB pathway
  publication-title: Cancer Res.,
  doi: 10.1158/0008-5472.CAN-17-1051
– volume: 32
  start-page: 1549
  year: 2013
  ident: 2022032516110725200_CIT0033
  article-title: TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers
  publication-title: Oncogene,
  doi: 10.1038/onc.2012.171
– volume: 9
  start-page: 8927
  year: 2018
  ident: 2022032516110725200_CIT0018
  article-title: Let-7c inhibits migration and epithelial-mesenchymal transition in head and neck squamous cell carcinoma by targeting IGF1R and HMGA2
  publication-title: Oncotarget,
  doi: 10.18632/oncotarget.23826
– volume: 9
  year: 2017
  ident: 2022032516110725200_CIT0012
  article-title: Signaling cross talk between TGF-beta/Smad and other signaling pathways
  publication-title: Cold Spring Harb. Perspect. Biol.,
  doi: 10.1101/cshperspect.a022137
– volume: 15
  start-page: 1722
  year: 2017
  ident: 2022032516110725200_CIT0015
  article-title: Genomic analysis of nasopharyngeal carcinoma reveals TME-based subtypes
  publication-title: Mol. Cancer Res.,
  doi: 10.1158/1541-7786.MCR-17-0134
– volume: 50
  start-page: 1749
  year: 2018
  ident: 2022032516110725200_CIT0019
  article-title: Taurine exhibits an apoptosis-inducing effect on human nasopharyngeal carcinoma cells through PTEN/Akt pathways in vitro
  publication-title: Amino Acids,
  doi: 10.1007/s00726-018-2651-2
– volume: 33
  start-page: 501
  year: 2003
  ident: 2022032516110725200_CIT0003
  article-title: Prognostic factors affecting the outcome of nasopharyngeal carcinoma
  publication-title: Jpn. J. Clin. Oncol.,
  doi: 10.1093/jjco/hyg092
– volume: 4
  start-page: 303
  year: 2013
  ident: 2022032516110725200_CIT0021
  article-title: How to calculate sample size in animal studies?
  publication-title: J. Pharmacol. Pharmacother.,
  doi: 10.4103/0976-500X.119726
– volume: 7
  start-page: 1056
  year: 2011
  ident: 2022032516110725200_CIT0035
  article-title: Diverse roles of TGF-β/Smads in renal fibrosis and inflammation
  publication-title: Int. J. Biol. Sci.,
  doi: 10.7150/ijbs.7.1056
– volume: 15
  start-page: 1765
  year: 2006
  ident: 2022032516110725200_CIT0001
  article-title: The enigmatic epidemiology of nasopharyngeal carcinoma
  publication-title: Cancer Epidemiol. Biomarkers Prev.,
  doi: 10.1158/1055-9965.EPI-06-0353
– volume: 110
  start-page: 398
  year: 2014
  ident: 2022032516110725200_CIT0004
  article-title: Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities
  publication-title: Radiother. Oncol.,
  doi: 10.1016/j.radonc.2013.10.020
– volume: 15
  start-page: 7693
  year: 2018
  ident: 2022032516110725200_CIT0026
  article-title: Downregulation of Frizzled-7 induces the apoptosis of hepatocellular carcinoma cells through inhibition of NF-κB
  publication-title: Oncol. Lett.,
– volume: 55
  start-page: 121
  year: 2009
  ident: 2022032516110725200_CIT0024
  article-title: [Epithelial-mesenchymal transition in cancer progression]
  publication-title: Postepy Biochem.,
– volume: 3
  start-page: 314
  year: 2001
  ident: 2022032516110725200_CIT0029
  article-title: Global methylation profiling of lung cancer identifies novel methylated genes
  publication-title: Neoplasia,
  doi: 10.1038/sj.neo.7900162
– volume: 13
  start-page: 1335
  year: 2019
  ident: 2022032516110725200_CIT0025
  article-title: Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway
  publication-title: Drug Des. Dev. Ther.,
  doi: 10.2147/DDDT.S199182
– volume: 127
  start-page: 1570
  year: 2010
  ident: 2022032516110725200_CIT0017
  article-title: Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization
  publication-title: Int. J. Cancer,
  doi: 10.1002/ijc.25173
SSID ssj0016359
Score 2.4296887
Snippet Abstract Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway...
Growth differentiation factor-10 (GDF10) belongs to a member of the transforming growth factor-β (TGF-β) superfamily. Dysfunction of the TGF-β pathway can lead...
SourceID proquest
pubmed
crossref
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 94
SubjectTerms Cell Line, Tumor
Cell Movement - genetics
Cell Proliferation - genetics
Epithelial-Mesenchymal Transition - genetics
Gene Expression Regulation, Neoplastic
Growth Differentiation Factor 10 - genetics
Humans
Nasopharyngeal Carcinoma - genetics
Nasopharyngeal Neoplasms - genetics
NF-kappa B - genetics
NF-kappa B - metabolism
Transforming Growth Factor beta - genetics
Transforming Growth Factor beta - metabolism
Title GDF10 inhibits cell proliferation and epithelial–mesenchymal transition in nasopharyngeal carcinoma by the transforming growth factor-β/Smad and NF-κB pathways
URI https://www.ncbi.nlm.nih.gov/pubmed/34922336
https://www.proquest.com/docview/2611653705
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LjtMwFLXKICE2iDflJYMYsRiFpnHqpstp51FAnQ0z0uwqO3HaiDYZtalGZcU_8An8AUs-Yj6CFZ_BvbHzYqgYkKooihzncU_sc2_vPSbkFRcOB9rBLL8rbMttKxe-OcGtjhd0ZSCECCUWOI-O-PDEfXfaOW00flayllapfON_-mNdyf9YFY6BXbFK9h8sW3QKB2Af7AtbsDBsr2Tjwz3wh3eieBpJjP9jEB4TrmaYrqINi2FxdYZ1FzO4nTyzgc2x5sifrudZqjnMVlGe8xgLXNdALNbxBCWHfVxqKE7mIqOpAKk0J7oYYpiAD59OzZo91vZgf7uPQqsf5iITgN05OtAHd_uo3zo9F-tllQwPdOcTHG6jZX1doCI-MdT5x8rMsBlr1ePT4SoJVVSG1DWwy3ajKEgW0UdxbqreksWqGuMA99hmllPGODfUTtbCosxizIRFlR7KXW5bQGDs6livJaEMpp3KwN1zKxSgnckuXJ5dtPKWfvOwIydCtnVV9W-a3ZsbXyPXHXBocK2Nvbfvi_-7gPb1dLKtfo5CXpS1dA8tc36NPtVKMi95RhlDOr5NbhnXhu5qnN4hDRXfJTdGJnnjHvmawZXmcKUIV1qDKwXQ0BKuPz5_qQCVlkCFPmgdqLQAKpVrCufTKlCpBio1QL341kKIZlcDiF5879McnvfJycH-8WBomTVCLJ85vdTiXhj6ricF-NFMMZjbO2HP7gqXu74fSJf7bYk-S8eTMoRfoFDizeui8h8LgME9IFtxEqtHhDLJw6AdcqBvgYv5CMB8Q9_2XJ_3HMWCJrHyVz_2jYA-ruMyG-tEDjbWjzo2pmqS10X7My0ds7HlS7DkXxu9yA09hikAbSRilayWY4ejhhbr2p0meagRUPSF4qMOY_zxVS7xhNwsv76nZCtdrNQz4NypfJ7B9Rf25ODP
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GDF10+inhibits+cell+proliferation+and+epithelial%E2%80%93mesenchymal+transition+in+nasopharyngeal+carcinoma+by+the+transforming+growth+factor-%CE%B2%2FSmad+and+NF-%CE%BAB+pathways&rft.jtitle=Carcinogenesis+%28New+York%29&rft.au=He%2C+Feng&rft.au=Feng%2C+Guofei&rft.au=Ma%2C+Ning&rft.au=Midorikawa%2C+Kaoru&rft.date=2022-03-24&rft.pub=Oxford+University+Press&rft.issn=0143-3334&rft.eissn=1460-2180&rft.volume=43&rft.issue=2&rft.spage=94&rft.epage=103&rft_id=info:doi/10.1093%2Fcarcin%2Fbgab122&rft.externalDocID=10.1093%2Fcarcin%2Fbgab122
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-3334&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-3334&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-3334&client=summon